加拿大过敏症患者中药物过敏管理的特征:一项全国调查研究
Erika Yue Lee1,2, Brian Lee3, Sinthiha Krishnan4
1Division of Allergy & Immunology, Department of Medicine, University of Toronto, Toronto, ON, Canada. erika.lee@mail.utoronto.ca.
概括
药物过敏测试实践在加拿大过敏学家之间有很大的差异,医院专家更经常进行测试. 诸如有限的护理支持等障碍妨碍了公平获得药物过敏测试的机会.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 临床实践管理的管理.
- 医疗保健系统研究 医疗保健系统研究
背景情况:
- 未经验证的药物过敏标签有助于伤害患者.
- 在加拿大的临床环境中存在不一致的药物过敏测试和管理基础设施.
研究的目的:
- 评估加拿大过敏学家之间的药物过敏管理变异性.
- 识别特定于临床环境的药物过敏测试和脱敏的障碍.
主要方法:
- 通过加拿大过敏和临床免疫学会向过敏学家分发了一份40项调查.
- 调查评估了实践模式,测试方式和感知的障碍.
- 描述性统计和费舍尔精确测试通过实践设置分析了反应.
主要成果:
- 在接受调查的过敏学家中,87.9%进行了药物过敏测试.
- 与社区的过敏学家相比,医院的过敏学家更有可能进行皮肤内检测,贴片检测和非口腔挑战.
- 缺乏护理支持和不充分的补偿是常见的障碍.
结论:
- 在加拿大药物过敏管理方面存在很大差异.
- 医院的过敏学家比社区的过敏学家更频繁地使用药物过敏测试.
- 需要公平地获得测试基础设施和系统级投资,以改善药物过敏测试服务.
相关概念视频
Allergic Drug Reactions
1.3K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.3K
Allergic Reactions
32.0K
Overview
32.0K
Hypersensitivities
7.2K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Upper Respiratory Drugs: First and Second-Generation Antihistamines
1.1K
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
1.1K


